John R. Moore, VP, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 200 shares at $5.79 ($1K) on 2013-11-13, disclosed to the SEC on 2013-11-15.
Scheduled sale ($1k) by VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |